Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Phentermine

Aliases
Adipex-P, Lomaira
Name
LOMAIRA
INN Name
Phentermine Hydrochloride
FDA Approved
Yes

5 clinical trials

4 organizations

3 indications

2 documents

Indication
Hypertension
Indication
Substance Use Disorder
Indication
Obesity
Clinical trial
A Multicenter, Randomized, Double-Blind Study to Compare the Effects of VI-0521,Phentermine, and Placebo on Ambulatory Blood Pressure in Overweight or Obese Subjects
Status: Completed, Estimated PCD: 2023-04-11
Clinical trial
A Double-Blind, Randomized, Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Istradefylline in Recreational Drug Users
Status: Completed, Estimated PCD: 2016-07-01
Clinical trial
Individualized Pharmacological Approach to Obesity Management: A Randomized Clinical Trial
Status: Completed, Estimated PCD: 2022-05-26
Clinical trial
Pilot Study of the Effect of Weight Loss by Pharmacotherapy on Chronic Pro-tumor Inflammatory Cells
Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
SMART Use of Medication for the Treatment of Adolescent Severe Obesity
Status: Active (not recruiting), Estimated PCD: 2024-08-31
Document
DailyMed Label: LOMAIRA
Organization
Calvin Scott & Co., Inc.
Document
DailyMed Label: Adipex-P
Organization
PD-Rx Pharmaceuticals, Inc.
Organization
KVK-Tech, Inc.
Organization
Teva Pharmaceuticals USA, Inc.